Lundbeck
Palle Holm Olesen is a seasoned professional in investor relations and equity analysis, currently serving as Chief Specialist in Investor Relations at H. Lundbeck A/S since December 2007. Prior experience includes roles as a Portfolio Manager at BankInvest and Investor Relations Manager at Novo Nordisk. Earlier in their career, Palle Holm Olesen worked as an equity analyst at Nykredit Bank, A/S Bjørnskov & Co., and Bikuben Børs A/S, focusing on healthcare, capital goods, transportation, and food & beverages. Palle Holm Olesen holds a Master’s degree in Strategic Planning from Copenhagen Business School and a high school diploma in Math and Biology from Ballerup Gymnasium.
This person is not in any teams
Lundbeck
43 followers
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.